N30.00

Acute cystitis without hematuria

Acute cystitis without hematuria refers to an acute inflammatory condition of the urinary bladder, primarily caused by bacterial infection, characterized by typical urinary symptoms but notably lacking gross hematuria. It is a common form of urinary tract infection (UTI), predominantly affecting women, and is generally considered an uncomplicated UTI when occurring in non-pregnant women with no underlying anatomical or functional urinary tract abnormalities or significant comorbidities. ## Pathophysiology ### Etiology and Predisposing Factors The vast majority of acute cystitis cases are caused by ascending bacterial infection, primarily from the periurethral and vaginal flora. *Escherichia coli* is the most common causative organism, responsible for 75-95% of infections. Other common pathogens include *Klebsiella pneumoniae*, *Proteus mirabilis*, *Staphylococcus saprophyticus*, and *Enterococcus faecalis*. The ascending route of infection is facilitated by several predisposing factors. In women, the shorter urethra, its proximity to the anus, and sexual activity are significant risk factors. Use of diaphragms and spermicides can alter vaginal flora, increasing susceptibility. Postmenopausal women are also at higher risk due to estrogen deficiency leading to atrophic changes in the vaginal and urethral epithelium, which can alter the vaginal microbiome and increase vaginal pH, favoring uropathogen colonization. In men, acute cystitis is less common and often indicative of an underlying urological issue, such as prostatic hypertrophy, prostatitis, or instrumentation. Other risk factors include urinary catheterization, diabetes mellitus, immunosuppression, and incomplete bladder emptying. ### Mechanism of Infection Bacteria, typically from the gastrointestinal tract, colonize the periurethral area and then ascend the urethra into the bladder. Virulence factors of uropathogenic *E. coli* (UPEC), such as fimbriae (e.g., P fimbriae, Type 1 fimbriae), enable adhesion to uroepithelial cells, preventing washout by micturition. Once adhered, bacteria can invade superficial umbrella cells, forming intracellular bacterial communities (IBCs), which protect them from antibiotics and host defenses, contributing to recurrent infections. The presence of bacterial toxins and inflammatory mediators triggers a robust immune response in the bladder wall, leading to the characteristic symptoms of inflammation. The absence of gross hematuria distinguishes this from acute cystitis with hematuria, though microscopic hematuria may still be present due to the inflammatory process. ## Clinical Presentation Patients with acute cystitis without hematuria typically present with a constellation of lower urinary tract symptoms. These commonly include dysuria (painful urination), urinary frequency (increased voiding episodes), urinary urgency (a sudden, compelling desire to void that is difficult to defer), and suprapubic discomfort or pressure. Nocturia (waking up at night to urinate) is also common. The key differentiating factor in this diagnosis is the absence of visible blood in the urine. Systemic symptoms such as fever, chills, and flank pain are usually absent; their presence suggests a more complicated infection, such as pyelonephritis, warranting further investigation. ## Diagnostic Criteria Diagnosis of acute cystitis without hematuria is often made clinically based on the presence of characteristic symptoms. However, laboratory confirmation is standard. ### Urinalysis A dipstick urinalysis is a rapid screening tool. Positive leukocyte esterase (indicating pyuria) and/or nitrites (indicating presence of gram-negative bacteria) are highly suggestive of UTI. Microscopic urinalysis typically reveals pyuria (defined as >10 white blood cells per high-power field) and bacteriuria. Microscopic hematuria might be present but is not a defining characteristic for this specific code. ### Urine Culture and Sensitivity While not always necessary for uncomplicated cystitis in women, a urine culture is the gold standard for confirming the diagnosis, identifying the specific causative organism, and determining its antibiotic susceptibility. It is particularly indicated in cases of recurrent UTIs, complicated UTIs (e.g., in men, pregnant women, patients with comorbidities), treatment failure, or atypical symptoms. A positive culture is generally defined as >10^5 colony-forming units (CFU)/mL for typical pathogens in a midstream clean-catch urine sample, though lower counts may be significant in symptomatic patients. ## Standard of Care and Management Treatment of acute cystitis without hematuria primarily involves short-course antibiotic therapy targeting common uropathogens. ### Antibiotic Therapy First-line oral antibiotics include trimethoprim-sulfamethoxazole (TMP-SMX), nitrofurantoin, and fosfomycin. The choice depends on local resistance patterns, patient allergies, and previous antibiotic exposure. For uncomplicated cases, a 3-day course of TMP-SMX or a 5-7 day course of nitrofurantoin is often effective. Fosfomycin is a single-dose option. Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) are highly effective but are generally reserved for more complicated infections or when other first-line agents are inappropriate due to concerns about increasing antimicrobial resistance and potential adverse effects. Phenazopyridine can be prescribed for symptomatic relief of dysuria. ### Follow-up and Prevention Follow-up urine cultures are typically not recommended for uncomplicated cases if symptoms resolve. Strategies for prevention of recurrent UTIs include adequate hydration, proper perineal hygiene, post-coital voiding, and sometimes prophylactic antibiotics in selected cases. The role of cranberry products and D-mannose remains a subject of ongoing research, with mixed evidence regarding their efficacy in preventing UTIs.

Clinical Symptoms

  • Dysuria (painful urination)
  • Urinary frequency (increased need to urinate)
  • Urinary urgency (sudden, compelling urge to urinate)
  • Suprapubic discomfort or pressure
  • Nocturia (waking up at night to urinate)
  • Feeling of incomplete bladder emptying
  • Cloudy urine
  • Foul-smelling urine
  • Absence of gross hematuria (visible blood in urine)
  • Absence of fever
  • Absence of chills
  • Absence of flank pain

Common Causes

  • Bacterial infection, predominantly *Escherichia coli* (75-95% of cases)
  • Other common uropathogens: *Klebsiella pneumoniae*, *Proteus mirabilis*, *Staphylococcus saprophyticus*, *Enterococcus faecalis*
  • Ascending infection from the periurethral area
  • Female anatomy (shorter urethra, proximity to anus)
  • Sexual activity
  • Use of diaphragms and spermicides
  • Estrogen deficiency in postmenopausal women
  • Urinary catheterization or instrumentation
  • Incomplete bladder emptying
  • Urological abnormalities (e.g., strictures, stones, vesicoureteral reflux)
  • Prostatic hypertrophy or prostatitis in men
  • Diabetes mellitus (compromised immune system, glucosuria)
  • Immunosuppression (e.g., HIV, transplant recipients, steroid use)
  • Genetic predisposition to recurrent UTIs

Documentation & Coding Tips

Always specify 'acute' and explicitly state 'without hematuria' when appropriate to ensure accurate coding of N30.00 and distinguish it from N30.01 (with hematuria).

Example: S: 32 y.o. female presents with sudden onset dysuria, urinary frequency, and urgency for 2 days. Denies gross hematuria, fever, flank pain. O: UA positive for leukocyte esterase and nitrites. Microscopic: >50 WBCs/hpf, no RBCs. A: Acute cystitis without hematuria (N30.00), likely bacterial. P: Rx Nitrofurantoin 100mg BID x 5 days. Return if symptoms worsen or persist. Billing Focus: Explicitly stating 'without hematuria' differentiates N30.00, preventing upcoding to N30.01. Risk Adjustment: Accurate diagnosis supports appropriate resource utilization but N30.00 typically does not have direct HCC impact unless associated with a complication or comorbidity like poorly controlled diabetes (E11.65). Documenting the lack of systemic symptoms (fever, flank pain) supports lower severity of illness.

Billing Focus: Specificity regarding the presence or absence of hematuria, directly impacts the choice between N30.00 and N30.01. Clear documentation avoids queries and ensures correct reimbursement.

Document the patient's history regarding recurrent UTIs or risk factors (e.g., sexual activity, diaphragm use, post-menopausal status, diabetes) as this informs management and potential future coding for recurrent episodes (N30.20, N39.0).

Example: S: 68 y.o. female, known Type 2 Diabetes Mellitus (E11.9, controlled with medication), presents with new onset dysuria and frequency. Reports a history of 3 UTIs in the past year, managed with antibiotics. O: Afebrile. UA positive for leukocyte esterase, nitrites. Urine culture sent. A: Acute cystitis without hematuria (N30.00) in a patient with recurrent UTI history and controlled T2DM. P: Rx Cephalexin 500mg BID x 7 days. Counsel on hydration and hygiene. Follow-up culture results. Billing Focus: Documenting 'recurrent UTI history' helps contextualize care, though N30.00 is acute. Linking to controlled T2DM (E11.9) provides a comorbidity. Risk Adjustment: While N30.00 itself is not an HCC, the underlying controlled T2DM (E11.9) carries an HCC. Documenting a history of recurrent UTIs provides context, and if the patient develops 'recurrent urinary tract infection' (N39.0 or N30.20 for chronic interstitial cystitis) in the future, it could impact risk adjustment if criteria are met for chronic conditions. Current episode is acute N30.00.

Billing Focus: Contextual information like 'recurrent UTI history' supports medical necessity for certain diagnostic tests or a more extensive E&M level. Documenting comorbidities like diabetes (E11.9) justifies a higher complexity of medical decision-making.

Identify the presumed causative organism or state 'unspecified' if not yet known, especially when initiating empiric antibiotic therapy. This enhances clinical detail and supports medical necessity.

Example: S: 45 y.o. female presents with acute dysuria, frequency, and suprapubic discomfort. Symptoms started yesterday. O: UA shows moderate leukocyte esterase and nitrites. Urine culture collected. A: Acute cystitis without hematuria (N30.00), suspected bacterial etiology (likely E. coli based on prevalence). P: Initiated empiric treatment with Trimethoprim/sulfamethoxazole DS BID x 3 days. Will adjust therapy based on culture and sensitivity results. Billing Focus: Documenting 'suspected bacterial etiology' and 'urine culture collected' justifies the empiric antibiotic prescription and the laboratory services. Risk Adjustment: While the organism itself doesn't directly impact N30.00's risk adjustment, specific organism identification (e.g., resistant organisms) would elevate the complexity of care and could be linked to future HCCs for resistant infections (Z16.X). For N30.00, the focus is on accurate diagnosis.

Billing Focus: Justifies antibiotic prescription and laboratory testing. If a specific organism (e.g., E. coli) is later confirmed, it supports the initial empiric treatment choice. Lack of organism specificity for N30.00 is acceptable if culture is pending.

Clearly differentiate symptoms of acute cystitis from those of pyelonephritis (e.g., flank pain, fever, chills, systemic illness) to avoid miscoding and potential over/under-coding of severity.

Example: S: 28 y.o. female with abrupt onset of severe dysuria and urinary urgency. Denies fever, chills, nausea, vomiting, or flank pain. O: Vital signs stable. Abdominal exam benign, no CVA tenderness. UA shows pyuria and bacteriuria. A: Acute cystitis without hematuria (N30.00). No evidence of pyelonephritis. P: Prescribed Fosfomycin 3g PO single dose. Educated on symptom resolution and warning signs of worsening infection. Billing Focus: Explicitly ruling out systemic symptoms like fever and flank pain supports the diagnosis of simple cystitis (N30.00) rather than more complex conditions like pyelonephritis (N10). This prevents incorrect upcoding. Risk Adjustment: Documenting absence of systemic signs (fever, flank pain) reinforces lower severity, which correctly reflects a lower risk burden. This helps avoid potential over-assignment of HCCs associated with more severe conditions like acute pyelonephritis (N10), which is an HCC.

Billing Focus: Crucial for distinguishing N30.00 from N10 (acute pyelonephritis). Clear documentation of 'no flank pain, no fever' justifies a lower E&M complexity for an uncomplicated cystitis and prevents audit flags for potential upcoding.

For patients presenting with urinary symptoms, ensure the chief complaint and history of present illness are congruent with the final diagnosis to support medical necessity and E&M level.

Example: S: Patient presents with new onset of painful urination and frequent urges for the past 24 hours. Describes burning sensation. Denies any blood in urine, vaginal discharge, or lower back pain. O: Physical exam unremarkable. UA positive for nitrites and leukocyte esterase. A: Acute cystitis without hematuria (N30.00). P: Prescribed Ciprofloxacin 250mg BID x 3 days. Discussed importance of completing full course. Billing Focus: Chief complaint (dysuria, frequency) and HPI (burning, new onset, 24 hours) align perfectly with the diagnosis N30.00, supporting the chosen E&M level for an acute, uncomplicated problem. Risk Adjustment: Consistent documentation of acute symptoms without complicating factors supports the accurate risk profile of a non-HCC condition, preventing unnecessary scrutiny for chronic conditions or those with higher severity scores.

Billing Focus: Clear alignment between subjective complaints, objective findings, and the final diagnosis strengthens the medical necessity for the visit and the selected E&M code, reducing audit risk.

Relevant CPT Codes

Related Diagnoses

Hierarchy